Aspergillus Species Causing Invasive Fungal Disease in Queensland, Australia

[1]  S. Chen,et al.  Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories. , 2022, Pathology.

[2]  D. Maubon,et al.  Can We Improve Antifungal Susceptibility Testing? , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  Sean X. Zhang,et al.  Aspergillus lentulus: An Under-recognized Cause of Antifungal Drug-Resistant Aspergillosis , 2021, Open forum infectious diseases.

[4]  M. Rolón,et al.  Triazole-Resistance in Environmental Aspergillus fumigatus in Latin American and African Countries , 2021, Journal of fungi.

[5]  A. Morris,et al.  Antifungal susceptibility of clinical mould isolates in New Zealand, 2001-2019. , 2021, Pathology.

[6]  K. Kamei,et al.  High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance. , 2020, Medical mycology.

[7]  C. Chao,et al.  Multicenter Study of Azole-Resistant Aspergillus fumigatus Clinical Isolates, Taiwan , 2020, Emerging infectious diseases.

[8]  A. Salamov,et al.  A comparative genomics study of 23 Aspergillus species from section Flavi , 2020, Nature Communications.

[9]  L. Cowen,et al.  Antifungal drug resistance: evolution, mechanisms and impact. , 2018, Current opinion in microbiology.

[10]  J. Guarro,et al.  Cryptic Aspergillus from clinical samples in the USA and description of a new species in section Flavipedes , 2018, Mycoses.

[11]  C. Beigelman-Aubry,et al.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  F. Lamoth.  Aspergillus fumigatus-Related Species in Clinical Practice , 2016, Front. Microbiol..

[14]  W. Ko,et al.  Azole‐resistant Aspergillus fumigatus isolates carrying TR34/L98H mutations in Taiwan , 2015, Mycoses.

[15]  B. Ener,et al.  First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  S. Seyedmousavi,et al.  International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[17]  J. Meis,et al.  Multi‐triazole‐resistant Aspergillus fumigatus infections in Australia , 2015, Mycoses.

[18]  P. Hauser,et al.  Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus , 2015, Emerging infectious diseases.

[19]  A. Chowdhary,et al.  Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired? , 2015, Journal of global antimicrobial resistance.

[20]  J. Boelens,et al.  Nationwide Surveillance of Azole Resistance in Aspergillus Diseases , 2015, Antimicrobial Agents and Chemotherapy.

[21]  A. Chowdhary,et al.  Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia , 2015, Front. Microbiol..

[22]  U. Groß,et al.  Environmental Isolates of Azole-Resistant Aspergillus fumigatus in Germany , 2015, Antimicrobial Agents and Chemotherapy.

[23]  P. Le Pape,et al.  First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France , 2015, Antimicrobial Agents and Chemotherapy.

[24]  T. Peláez,et al.  First detection of Aspergillus fumigatus azole-resistant strain due to Cyp51A TR46/Y121F/T289A in an azole-naive patient in Spain , 2015, New microbes and new infections.

[25]  J. Meis,et al.  Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures. , 2015, The Journal of antimicrobial chemotherapy.

[26]  A. Chowdhary,et al.  Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. , 2014, The Journal of antimicrobial chemotherapy.

[27]  F. Dromer,et al.  Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010 , 2014, Emerging infectious diseases.

[28]  O. Hilberg,et al.  First Detection of TR46/Y121F/T289A and TR34/L98H Alterations in Aspergillus fumigatus Isolates from Azole-Naive Patients in Denmark despite Negative Findings in the Environment , 2014, Antimicrobial Agents and Chemotherapy.

[29]  K. Yuen,et al.  Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: Characterization by Internal Transcribed Spacer, β-Tubulin, and Calmodulin Gene Sequencing, Metabolic Fingerprinting, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry , 2014, Journal of Clinical Microbiology.

[30]  T. Peláez,et al.  Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study) , 2013, Antimicrobial Agents and Chemotherapy.

[31]  F. V. van Tiel,et al.  Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  Ronald N. Jones,et al.  In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds , 2013, Journal of Clinical Microbiology.

[33]  B. Lebeau,et al.  Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  E. Kuijper,et al.  Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature , 2011, Antimicrobial Agents and Chemotherapy.

[35]  F. V. van Tiel,et al.  Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009 , 2011, Emerging infectious diseases.

[36]  S. Lockhart,et al.  Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene , 2011, Antimicrobial Agents and Chemotherapy.

[37]  A. Warris,et al.  Aspergillus species intrinsically resistant to antifungal agents. , 2011, Medical Mycology.

[38]  B. Alexander,et al.  Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network , 2009, Journal of Clinical Microbiology.

[39]  D. Denning,et al.  Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure , 2009, Emerging infectious diseases.

[40]  W. Melchers,et al.  Academic Editor: Chris Kibbler, Royal Free Hospital London, United Kingdom , 2007 .